Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Neuralink's "Blindsight" vision restoration implant receives FDA's "breakthrough device" designation.
Neuralink, Elon Musk's neurotechnology startup, has received "breakthrough device" designation from the U.S. FDA for its vision restoration implant, "Blindsight."
This designation expedites the development of devices treating life-threatening conditions.
The implant aims to assist those who are blind, bypassing damaged optic pathways.
Neuralink is also testing technology that allows paralyzed patients to control digital devices with their thoughts, with trials expected to last several years.
68 Articles
El implante de restauración de visión "Blindsight" de Neuralink recibe la designación de "dispositivo de avance" de la FDA.